Labcorp (LH) to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the U.S., offering First to Know® Syphilis Test nationwide BURLINGTON, N.C., Oct 10, 2024 /PRNewswire/ ...
As syphilis rates rise at an alarming rate in Tennessee and across the nation, the U.S. Food and Drug Administration approved the first over-the-counter home syphilis test. While the test won't be ...
SPRINGDALE, Ark.--(BUSINESS WIRE)--NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that its First To Know® Syphilis Test—a ...
MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV
The Multiplo® TP/HIV rapid test allows healthcare professional to accurately detect both HIV-1/2 and syphilis antibodieswith one sample using a simple finger prick that delivers results immediately.
In a busy clinic in Jackson, Mississippi, a clinician performs a rapid syphilis test on a pregnant woman. Within 15 minutes, the results are in — she is infected — and treatment can begin immediately.
The FDA granted a green light to its first at-home, over-the-counter test to detect a person’s exposure to syphilis, offering a private option to help detect the sexually transmitted infection.
HALIFAX, NOVA SCOTIA / ACCESS Newswire / August 26, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received approval from Health Canada for its Reveal® TP (Syphilis) Antibody ...
Cornelis A. Rietmeijer, More Mungati, Peter H. Kilmarx, Beth Tippett Barr, Elizabeth Gonese, Ranmini S. Kularatne, David A. Lewis, Jeffrey D. Klausner, Luanne Rodgers ...
PROVIDENCE, R.I. & HALIFAX, Nova Scotia--(BUSINESS WIRE)--Maternova, Inc., accelerating advances in maternal and infant health through innovative, accessible solutions, and MedMira Inc. (TSXV: MIR), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback